Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Failure of SCID-X1 gene therapy in older patients.

Thrasher AJ, Hacein-Bey-Abina S, Gaspar HB, Blanche S, Davies EG, Parsley K, Gilmour K, King D, Howe S, Sinclair J, Hue C, Carlier F, von Kalle C, de Saint Basile G, le Deist F, Fischer A, Cavazzana-Calvo M.

Blood. 2005 Jun 1;105(11):4255-7. Epub 2005 Feb 1.

2.

Treatment of an infant with X-linked severe combined immunodeficiency (SCID-X1) by gene therapy in Australia.

Ginn SL, Curtin JA, Kramer B, Smyth CM, Wong M, Kakakios A, McCowage GB, Watson D, Alexander SI, Latham M, Cunningham SC, Zheng M, Hobson L, Rowe PB, Fischer A, Cavazzana-Calvo M, Hacein-Bey-Abina S, Alexander IE.

Med J Aust. 2005 May 2;182(9):458-63.

PMID:
15865589
3.

Gene therapy of X-linked severe combined immunodeficiency.

Hacein-Bey-Abina S, de Saint Basile G, Cavazzana-Calvo M.

Methods Mol Biol. 2003;215:247-59. No abstract available.

PMID:
12512304
4.

[Gene therapy of X-linked severe combined immunologic deficiency (SCID-X1)].

Hacein-Bey S, Gross F, Nusbaum P, Yvon E, Fischer A, Cavazzana-Calvo M.

Pathol Biol (Paris). 2001 Feb;49(1):57-66. Review. French.

PMID:
11265225
5.

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease.

Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, Gross F, Yvon E, Nusbaum P, Selz F, Hue C, Certain S, Casanova JL, Bousso P, Deist FL, Fischer A.

Science. 2000 Apr 28;288(5466):669-72.

6.

Gene therapy in infants with severe combined immunodeficiency.

Otsu M, Candotti F.

BioDrugs. 2002;16(4):229-39. Review.

PMID:
12196037
7.

Gene therapy of X-linked severe combined immunodeficiency.

Cavazzana-Calvo M, Hacein-Bey-Abina S, Fischer A.

Curr Opin Allergy Clin Immunol. 2002 Dec;2(6):507-9. Review.

PMID:
14752333
8.

Efficacy of gene therapy for SCID is being confirmed.

Cavazzana-Calvo M, Fischer A.

Lancet. 2004 Dec 18-31;364(9452):2155-6. No abstract available.

PMID:
15610783
9.

Occurrence of leukaemia following gene therapy of X-linked SCID.

Kohn DB, Sadelain M, Glorioso JC.

Nat Rev Cancer. 2003 Jul;3(7):477-88. Review. Erratum in: Nat Rev Cancer. 2003 Nov;3(11):883.

PMID:
12835668
10.

Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector.

Gaspar HB, Parsley KL, Howe S, King D, Gilmour KC, Sinclair J, Brouns G, Schmidt M, Von Kalle C, Barington T, Jakobsen MA, Christensen HO, Al Ghonaium A, White HN, Smith JL, Levinsky RJ, Ali RR, Kinnon C, Thrasher AJ.

Lancet. 2004 Dec 18-31;364(9452):2181-7.

PMID:
15610804
11.

Gene therapy of severe combined immunodeficiencies.

Cavazzana-Calvo M, Hacein-Bey S, Yates F, de Villartay JP, Le Deist F, Fischer A.

J Gene Med. 2001 May-Jun;3(3):201-6. Review.

PMID:
11437325
13.

Successful transplantation of haploidentical CD34+ selected bone marrow cells for an infantile case of severe combined immunodeficiency with aspergillus pneumonia.

Yoshihara T, Morimoto A, Nakauchi S, Fujii N, Tsunamoto K, Misawa A, Hibi S, Imashuku S.

Pediatr Hematol Oncol. 2002 Sep;19(6):439-43.

PMID:
12186368
14.

Long-term outcomes of nonconditioned patients with severe combined immunodeficiency transplanted with HLA-identical or haploidentical bone marrow depleted of T cells with anti-CD6 mAb.

Patel NC, Chinen J, Rosenblatt HM, Hanson IC, Brown BS, Paul ME, Abramson SL, Ritz J, Shearer WT.

J Allergy Clin Immunol. 2008 Dec;122(6):1185-93. doi: 10.1016/j.jaci.2008.10.030.

PMID:
19084111
15.

Gene therapy for severe combined immunodeficiencies.

Gaspar HB, Thrasher AJ.

Expert Opin Biol Ther. 2005 Sep;5(9):1175-82. Review.

PMID:
16120048
17.

Gene therapy for severe combined immune deficiency.

Qasim W, Gaspar HB, Thrasher AJ.

Expert Rev Mol Med. 2004 Jul 2;6(13):1-15. Review.

PMID:
15236670
18.

Gene therapy for primary immunodeficiency diseases: recent progress and misgivings.

Ariga T.

Curr Pharm Des. 2006;12(5):549-56. Review.

PMID:
16472146
19.
20.

Gene therapy. Panel urges limits on X-SCID trials.

Kaiser J.

Science. 2005 Mar 11;307(5715):1544-5. No abstract available.

PMID:
15761128

Supplemental Content

Support Center